Clinical trial Recruiting at 1 site Interventional Ages 18 to 30 Women only

Graded Motor Imagery for Primary Dysmenorrhea

Official title: Effect of Graded Motor Imagery on Pressure Pain Threshold and Pain Intensity in Women With Primary Dysmenorrhea: A Randomized Controlled Trial

Run by University of Health Sciences Lahore · NCT07618832 · Data updated 2026-11-12

This study tests whether graded motor imagery can lessen menstrual pain and sensitivity in young women with primary dysmenorrhea.

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexWomen only
Enrollment81 (estimated)
SponsorUniversity of Health Sciences Lahore
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedApril 6, 2026
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedJune 2, 2026
Trial IDNCT07618832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18-30 with physician-confirmed primary dysmenorrhea, experiencing pain at least 4/10 during last period and with altered pressure pain threshold.

Probably not a fit

Individuals without central sensitization, those with secondary dysmenorrhea, or those unable to engage in online sessions may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, three-arm trial examines whether a full graded motor imagery (GMI) program, a sham GMI program, or no intervention can reduce pain sensitivity and menstrual pain in women with primary dysmenorrhea. Participants complete a 6-week online-delivered program including laterality recognition, motor imagery, and mirror therapy, with assessments before, after, and at a follow-up to measure pain intensity, pressure pain threshold, and pain catastrophizing. The trial targets central sensitization and altered pain processing as potential mechanisms underlying dysmenorrhea. It is not currently testing a pharmacological treatment and uses non-invasive, brain-directed therapy. The study is grounded in prior evidence of GMI benefits in other chronic pain conditions but applies it to menstrual pain for the first time.

Why it matters

Potential benefit: If successful, GMI could provide a non-pharmacological option to reduce menstrual pain and improve pain coping in someone with primary dysmenorrhea.

How similar studies have gone: GMI has shown benefits in other chronic pain conditions, but its effectiveness for primary dysmenorrhea is being tested for the first time in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female sex (aged 18-30 years)
2. Diagnosis of primary dysmenorrhea confirmed by a physician (painful menstruation for ≥6 consecutive cycles, in the absence of identifiable pelvic pathology on clinical and/or ultrasound evaluation)
3. Pain ≥4/10 NRS experienced during the last period.
4. Confirmed altered pressure pain threshold: PPT ≥2 standard deviations below published norms for age-matched healthy women, measured at baseline assessment
5. Regular menstrual cycle (21-35 days)
6. Capable of engaging in virtual video sessions and taking online tests.
7. Consent to withhold new analgesic or hormonal treatments during the study period.

Exclusion Criteria:

1. Secondary dysmenorrhea (endometriosis, adenomyosis, fibroids, pelvic inflammatory disease, ovarian cysts ≥3 cm confirmed on imaging)
2. Current use of hormonal contraceptives (which alter prostaglandin levels and pain processing)
3. Pregnancy or lactation
4. Concurrent chronic pain condition (fibromyalgia, CRPS, chronic low back pain, chronic pelvic pain unrelated to menstruation)
5. Neurological or psychiatric disorder that would impair motor imagery ability (stroke, schizophrenia, active psychosis)
6. Cognitive impairment affecting informed consent capacity
7. Participation in another clinical trial within 4 weeks before enrollment
8. Previous exposure to graded motor imagery or mirror therapy
9. Regular use of NSAIDs or opioids for non-menstrual indications

Where it's running

  • Dr. Saqib Rabbani
    Lahore, Punjab Province, Pakistan
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.